Abstract
Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.
| Original language | English |
|---|---|
| Article number | 22761 |
| Journal | Journal of Market Access and Health Policy |
| Volume | 2 |
| Issue number | 1 |
| Early online date | 1 Apr 2014 |
| DOIs | |
| Publication status | Published - 2014 |
| Externally published | Yes |
Bibliographical note
Funding Information:This article has been partly supported by an educational grant from Université Claude Bernard Lyon I, France.
Publisher Copyright:
© 2014 Mart oude Egbrink and Maarten IJzerman.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'The value of quantitative patient preferences in regulatory benefit-risk assessment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver